Results 311 to 320 of about 754,612 (422)
Abstract Compared to traditional small molecule drugs, monoclonal antibodies (mAbs) often display more complex pharmacokinetic (PK) and pharmacodynamic (PD) properties that may be impacted by disease‐specific factors. For mAbs in non‐oncology indications, where the same drug might be used for conditions involving different organ systems and/or having ...
Sherouk M. Tawfik, Fei Tang
wiley +1 more source
The DSC Index: A new prognostic tool for evaluating functional status in interstitial lung disease. [PDF]
Kchaou K+4 more
europepmc +1 more source
Interstitial lung disease recurrence on chemotherapy rechallenge in breast cancer: a nationwide Japanese database. [PDF]
Nishijima S+4 more
europepmc +1 more source
Abstract Background Subspecialty inpatient care is associated with improved outcomes in various clinical settings. However, clinical outcomes and racial disparities between dedicated inpatient pulmonary care and general medicine services with pulmonary consultation remain unknown.
Bhavik P. Patel+3 more
wiley +1 more source
Efficacy and safety of pleurodesis for lung cancer patients with interstitial lung disease. [PDF]
Iso H+15 more
europepmc +1 more source
Persistence of EEG abnormalities in KCNT1‐related DEE in an adult patient
Epileptic Disorders, EarlyView.
Haania Kakwan+3 more
wiley +1 more source
ABSTRACT Hyperpolarized (HP) gas pulmonary MR ventilation images are typically quantified using ventilation defect percent (VDP); however, the test‐retest variability of VDP has not been systematically established in multi‐center trials. Herein, we perform a systematic review of the test‐retest literature on the variability of VDP, and similar metrics,
Vanessa M. Diamond+15 more
wiley +1 more source
Dynapenia and Sarcopenia as Risk Factors for Mortality in Interstitial Lung Disease. [PDF]
Ibarra-Fernández AA+11 more
europepmc +1 more source
ABSTRACT The aging of the world population gave rise to an increased prevalence of many lung diseases, with chronic obstructive pulmonary disease now ranking as the third‐leading cause of death according to the World Health Organization. To diagnose lung disease, a thorough assessment of lung function is essential since it may reveal unique signatures ...
Agilo L. Kern+4 more
wiley +1 more source